Chemomab Therapeutics Announces First Quarter 2022 Financial Results and Provides Corporate Update May 12, 2022 06:00AM
Chemomab Therapeutics to Participate in Cantor Fitzgerald Rare Orphan Disease Summit Mar 23, 2022 07:00AM
Cantor Fitzgerald Starts Chemomab Therapeutics (CMMB) at Overweight May 26, 2021 06:35AM